tirzepatide 7.5mg (Mounjaro®) Program — Japan Sourced · Rx · Weekly Injection Mounjaro (Tirzepatide) Injection 7.5 mg/0.5

Report the side effects to your doctor timely manner to avoid long-term effects and suggest an appropriate dose according to your health condition

[1] [2] Gastrointestinal side effects are typically most pronounced during dose escalation and often diminish with continued treatment

Foods and drinks with high sugar content

The general adult weight-management indication includes patients with an initial: BMI of 30 kg/m2 or above, or BMI from 27 kg/m2 to below 30 kg/m2 with at least one weight-related health condition Relevant conditions may include: high blood pressure abnormal cholesterol levels obstructive sleep apnoea cardiovascular disease prediabetes type 2 diabetes Meeting these general criteria does not guarantee that treatment will be prescribed

however, the primary active ingredients in our products, semaglutide and tirzepatide, are the same as those in FDA-approved drugs